Ziresovir, an antiviral drug targeted at respiratory syncytial virus (RSV), was superior to placebo in reducing signs and ...

The next-generation sequencing test, infexn, developed by HaystackAnalytics, is a genomics-based test capable of detecting ...

“It is common for newborn babies to make all sorts of sounds, from occasional snorts to grunts, gurgles to whistling,” the ...

Naobios and European Vaccine Initiative partner up to manufacture Respiratory Syncytial Virus (RSV) challenge agent Collaborat ...

The Eastern Ontario Health Unit is advising a new treatment is now available in the region to help protect infants from the ...

Researchers from Brigham and Women’s Hospital published new research in Science Translational Medicine showing that natural ...

EDP-323 is an investigational inhibitor of Respiratory Syncytial Virus (RSV), currently showing promising results in Phase 2a ...

Here are the top medical news for the day:1 in 4 Adults Suspect They Have Undiagnosed ADHDA new national survey of 1,000 ...

Pfizer has reportedly ended its Phase II/III trials for sisunatovir, a promising RSV candidate acquired with ReViral in a ...

COVID-19 disrupted established patterns of seasonal transmission for several major respiratory Illnesses, with the exception of rhinovirus.

Colorado's health department is working to get more information out to the public about circulating respiratory viruses. It’s ...

GSK & ViiV Healthcare to showcase advances across industry-leading infectious disease portfolio at IDWeek 2024: London, UK Monday, October 14, 2024, 14:00 Hrs [IST] GSK plc and Vi ...